Evaluation of prolactin-like activity produced by concanavalin-A stimulated mouse splenocytes☆
-
Add time:09/07/2019 Source:sciencedirect.com
The prolactin (PRL)-like activity released into synthetic culture medium from concanavalin-A (Con-A)-stimulated mouse splenocytes was bioassayed using 3H thymidine incorporation into Nb2 lymphoma cells. At low cell density (1.0 × 106 cells/ml medium) Con-A-stimulated splenocytes from Balb/c mice released more PRL-like activity than did splenocytes from normal C3HHeJ mice. This difference was maintained with animals of either sex, and for animals of different ages (1, 3 and 5 months). The strain difference was observed both when splenocytes were cocultured with Nb2 cells, and when postcultured medium from splenocytes was tested. Con-A-stimulated splenocytes also released a substance into the medium which was inhibitory to PRL-induced Nb2 cell proliferation. The concentration of the inhibitory substance in the medium was related to the number of splenocytes in culture and was similar in splenocyte media preparations from both strains of mice. Polyclonal antisera to bovine PRL, rat PRL, mouse placental lactogen II, and mouse PRL did not neutralize the effect of Con-A-stimulated splenocytes to induce Nb2 cell proliferation. Bioassay of the partially purified PRL-like activity found in postcultured medium indicated that the dose-dependent induction of Nb2 cell proliferation was parallel with that of purified mPRL. Using two mouse PRL antisera (Sinha and Talamantes #118) in Western blot analyses, no antibody binding was observed to the partially-purified splenocyte PRL-like material. The data from the antisera neutralization experiments and the SDS/PAGE Western blot analyses clearly indicated that the PRL-like activity produced by Con-A-stimulated splenocytes has little homology with pituitary PRL. Further studies are required to establish the precise molecular identity of the PRL-like activity from Con-Astimulated splenocytes.
We also recommend Trading Suppliers and Manufacturers of prolactin-like protein IV (cas 136253-31-1). Pls Click Website Link as below: cas 136253-31-1 suppliers
Prev:Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein
Next:CommunicationPromoter-specific involvement of the FixJ receiver domain in transcriptional activation1) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein09/06/2019
- Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease09/05/2019
- Potential Genes for Regulation of Milk Protein Synthesis in Dairy Goat Mammary Gland09/04/2019
- ReviewBlood-based protein biomarkers in breast cancer09/03/2019
- Differential effects of protein malnutrition in pregnant rats on the expression of placental prolactin-like proteins09/02/2019
- Expression and characterization of recombinant rat placental prolactin-like protein C09/01/2019
- Regular paperA novel cDNA clone encoding a prolactin-like protein that lacks the two C-terminal cysteine residues isolated from bovine placenta08/31/2019
- Role of prolactin-like protein (PRL-L) in cold-induced increase of muscle mass in chicks08/30/2019
-
Health and Chemical more >


